Screening for Preeclampsia in Norway With Aspirin Discontinuation at 24-28 Weeks
Screening for Preeclampsia in Norway With Aspirin Discontinuation at 24-28 Weeks
Active, not recruiting · NCT06108947 · Registry updated 2026-10-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Screening for Preeclampsia in Norway With Aspirin Discontinuation at 24-28 Weeks | Female Urogenital Diseases and Pregnancy Complications, Urogenital Diseases, hypertension, pregnancy-induced, preeclampsia, pregnancy disorder | Active, not recruiting | Not applicable | 2026-10-06 | NCT06108947 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| St. Olavs Hospital | 167 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| St. Olavs hospital | Trondheim | Norway | 17 |